Trelagliptin Succinate (CAS 1029877-94-8)
« Back to Anti-Diabetes API
Trelagliptin Succinate
CAS No. 1029877-94-8
琥珀酸曲格列汀
Chemical structure
| CAS No. | 1029877-94-8 |
|---|---|
| Synonyms | — |
| Category | Anti-Diabetes API / Anti-Diabetes |
| Assay / Purity | 99% |
| Molecular Formula | C22H26FN5O6 |
| Molecular Weight | 475.5 |
| Melting Point | — |
| Boiling Point | — |
| Density | — |
| Flash Point | — |
| Appearance | Off-white to white solid powder |
Application and positioning
Trelagliptin succinate is a long-acting DPP-4 inhibitor supplied as the succinate salt. It is used in once-weekly oral tablets for type 2 diabetes, a regimen developed to improve adherence. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.
Quality and documentation
- Batch-specific Certificate of Analysis issued by the manufacturing site
- SDS/MSDS and specification sheet available on request
- Residual solvents and elemental impurities statements discussed per project
- For pharmaceutical manufacturing and R&D use only — not for direct administration
Packaging and handling
- Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
- Small quantities in sealed aluminium foil bags
- Palletised for air and sea freight; store dry, ventilated and protected from light
Related products
- Dapagliflozin (CAS 461432-26-8)
- Empagliflozin (CAS 864070-44-0)
- Ertugliflozin L-Pyroglutamic Acid (CAS 1210344-83-4)
- Linagliptin (CAS 668270-12-0)
- 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride (CAS 762240-92-6)
Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.
Interested in this product?
Contact us for price, COA, MSDS and lead time — custom synthesis available.
Request a QuoteReference: CAS 1029877-94-8 · PubChem CID 44183569